Incidence and predictors of all-cause and site-specific cancer in type 2 diabetes: the Fremantle Diabetes Study.
Abstract
OBJECTIVE
To explore the relationship between diabetes and cancer.
DESIGN
The Fremantle Diabetes Study (FDS) was a community-based longitudinal observational study of 1426 subjects, 1294 of which
had type 2 diabetes.
METHODS
The FDS type 2 cohort and four age-, sex- and postcode-matched controls per case were followed for cancer events from 1993
until mid-2010 and incidence rate ratios (IRRs) were calculated. Competing risks proportional hazards models generated risk
factors for incident cancers in the diabetic group.
RESULTS
There were 309 first cancers over 13 051 patient-years, or 2368 (95% confidence interval (95% CI) 2111-2647)/100 000 patient-years
in the diabetes patients vs 1131 over 60 324 patient-years (1875 (1769-1987)/100 000 patient-years) in the controls. For those
aged ≥45 years, the risk of all-cause cancer was elevated in type 2 diabetic men (IRRs 1.23, 95% CI 1.04-1.45) and women (1.30,
1.06-1.59). The incidence of colorectal cancer was increased (1.36, 1.01-1.82), especially in diabetic men aged 75-84 years
(2.14, 1.22-3.64). Age at diabetes diagnosis (sub-hazard ratio 1.05, 1.02-1.09), calcium channel blocker therapy (2.37, 1.39-4.06),
recent exercise (2.11, 1.06-4.20) and serum total cholesterol (0.68, 0.52-0.88) increased colorectal cancer risk. Pancreatic
cancer was also more frequent in the diabetic patients (IRR 2.26, 1.20-4.10). Diabetic men and women had similar risks of
prostate and breast cancer to those of controls (0.83, 0.59-1.14 and 0.86, 0.52-1.36).
CONCLUSIONS
Type 2 diabetes is associated with a moderately increased cancer risk in well-characterised community-based patients, especially
pancreatic cancer and colorectal cancer in older men. Recommended cancer screening should be considered as part of routine
diabetes management.
Links
Authors
Magliano DJ, Davis WA, Shaw JE, Bruce DG, Davis TM
Institution
Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Source
European journal of endocrinology / European Federation of Endocrine Societies 167:4 2012 Oct pg 589-99MeSH
AgedAged, 80 and over
Australia
Cohort Studies
Diabetes Mellitus, Type 2
Female
Hospitalization
Humans
Incidence
Longitudinal Studies
Male
Neoplasms
Organ Specificity
Prognosis
Registries
Risk Factors
Pub Type(s)
Journal ArticleResearch Support, Non-U.S. Gov't
Language
eng
PubMed ID
22893694
Log In

